Press release
Gene Fusion Testing Market to Reach USD 2.5 Billion by 2035 as Precision Medicine Drives Industry Growth
Gene Fusion Testing Market
👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86836
Market Overview
The gene fusion testing market is set to experience substantial expansion over the next few years, largely due to the continuous upgradations in genomic technologies and increased involvement of gene fusion in different cancers. Gene fusion events are pivotal in cancer diagnostics and targeted therapies, which are generally used in cancer types like lung cancer, leukemia, and sarcomas.
In addition, the rising incidences of cancer and the demand for personalized treatment options are the main factors that contribute to the market growth. The use of innovative technologies like next-generation sequencing (NGS) and real-time PCR has greatly increased the sensitivity and specificity of gene fusion detection.
Analysts' Viewpoint
Gene fusion testing is a major source of information used by oncologists to know what gene fusions are. They are the sequences where two genes combine to form a new one. These fusions, which have been identified in lung cancer, breast cancer, and blood cancers mostly, are usually at the forefront of cancer biomarkers.
In general, gene fusion detection leverages molecular features through instruments such as next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), and reverse transcription-polymerase chain reaction (RT-PCR) to precisely identify fusion genes and promote the use of personalized medicine, which allows clinicians to decide on the best therapies suitable for the specific genetic changes that take place in a patient's tumor.
The utility of gene fusion testing in the determination of the most appropriate therapeutics, in the tracking of cancer development, and in the prediction of cancer patient survivability, is growing in parallel with the awareness of cancer genomics. Educational and technological enhancement in gene fusion detection will, thus, lead to quick integration of gene fusion testing into daily clinical routine and result in the precision therapy of cancer being further refined.
Analysis of Key Players
The competitive landscape is characterized by technological innovation, strategic collaborations, regulatory approvals, and expansion of precision diagnostics portfolios.
Leading companies operating in the global gene fusion testing market include:
• Amoy Diagnostics Co., Ltd.
• ArcherDX (Integrated DNA Technologies, Inc.)
• Biocartis
• Biocare Medical, LLC
• F. Hoffmann-La Roche Ltd.
• Guardant Health, Inc
• Illumina, Inc.
• Myriad Genetics, Inc.
• Natera, Inc.
• NeoGenomics, Inc.
• QIAGEN N.V.
• Thermo Fisher Scientific Inc
• Other Prominent Players
Strategic investments in next-generation sequencing platforms, companion diagnostics, liquid biopsy technologies, and precision oncology solutions remain key competitive strategies among market participants.
Recent Developments (2024-2025)
• In July 2025, Thermo Fisher Scientific received FDA's approval for its Oncomine Dx Express Test (on the Ion Torrent Genexus Dx) as a companion diagnostic and tumor-profiling NGS assay, a milestone that also impacts fusion detection workflows.
• In October 2025, Gene Solutions and AMPATH launched a new advanced genomics laboratory in Hyderabad (India) to expand access to NGS-based testing (including oncology/precision medicine, which implicates fusion testing) in the region.
• In September 2024, NeoGenomics, Inc. announced real-world data to be presented at ESMO 2024 showing that testing for 19 drug-targetable gene fusions via NGS identified up to four times more patients eligible for matched therapies compared to tests focusing only on NTRK fusions or using IHC.
👉 Discuss Implications for Your Industry Request Sample Market Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=86836
Key Developments & Trends
• Expansion of Precision Medicine: Growing adoption of biomarker-driven cancer diagnosis and treatment.
• Next-Generation Sequencing (NGS): Increasing use of comprehensive genomic profiling platforms.
• Companion Diagnostics Growth: Rising demand for tests supporting targeted therapies.
• Liquid Biopsy Innovation: Expanding use of non-invasive molecular diagnostic technologies.
• AI & Bioinformatics Integration: Improved interpretation of complex genomic data.
Challenges
• High Testing Costs: Advanced molecular diagnostics remain expensive in many healthcare systems.
• Complex Data Interpretation: Specialized expertise is required for genomic analysis.
• Regulatory Requirements: Diagnostic assays must comply with rigorous clinical validation standards.
• Limited Access in Developing Regions: Infrastructure and reimbursement challenges may restrict adoption.
Opportunities
• Rising Global Cancer Burden: Increasing demand for molecular oncology diagnostics.
• Expansion of Targeted Therapies: Growth in precision oncology drives companion diagnostic adoption.
• Technological Advancements: Innovation in NGS, RT-PCR, and liquid biopsy platforms.
• Emerging Healthcare Markets: Improving genomic medicine infrastructure supports market expansion.
Market Segmentation
By Category
• Research
• Diagnostic
By Technology
• Next-Generation Sequencing (NGS)
• Fluorescence In-Situ Hybridization (FISH)
• Polymerase Chain Reaction (PCR)
• Immunohistochemistry (IHC)
By Indication
• Solid Tumors
• Hematological Malignancies
By End-user
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Academic and Research Centers
Conclusion
The gene fusion testing market is expected to witness robust growth through 2035, driven by increasing adoption of precision medicine, expanding use of molecular diagnostics, and growing availability of targeted cancer therapies. Continuous advancements in next-generation sequencing, liquid biopsy, AI-enabled genomic analysis, and companion diagnostics will further accelerate market development. As healthcare systems increasingly prioritize personalized oncology care, gene fusion testing will remain a critical component of modern cancer diagnosis and treatment selection.
👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=86836<ype=S
Frequently Asked Questions
• How big was the global gene fusion testing market in 2024?
It was valued at US$ 0.7 Bn in 2024
• What is the projected size of the gene fusion testing market by 2035?
It is projected to cross US$ 2.5 Bn by the end of 2035
• What are the factors driving the gene fusion testing market?
Increasing incidence of cancer and rising demand for personalized medicine
• What is the gene fusion testing industry expected to grow during the forecast period?
It is anticipated to grow at a CAGR of 12.1% from 2025 to 2035
• Which region is expected to dominate the gene fusion testing market during the forecast period?
North America is expected to account for the largest share from 2025 to 2035
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Fusion Testing Market to Reach USD 2.5 Billion by 2035 as Precision Medicine Drives Industry Growth here
News-ID: 4581572 • Views: …
More Releases from Transparency Market Research
Flap Wheel Market to Reach US$ 1.21 Billion by 2035, Driven by Rising Demand for …
The global flap wheel market is witnessing steady growth as industries increasingly prioritize precision grinding, polishing, deburring, and surface finishing operations. Flap wheels are abrasive tools made with overlapping abrasive flaps attached around a central core, enabling consistent material removal while maintaining superior surface quality. Their flexibility and durability make them ideal for both handheld power tools and stationary machines across automotive, aerospace, metal fabrication, construction, woodworking, and industrial manufacturing…
Power Transmission and Distribution EPC Market to Reach US$ 377.7 Billion by 203 …
The global Power Transmission and Distribution EPC Market is experiencing steady growth as countries invest in modernizing electricity infrastructure to meet rising energy demand and support renewable power integration. Engineering, Procurement, and Construction (EPC) services play a crucial role in designing, building, and upgrading transmission lines, substations, transformers, and distribution networks that ensure reliable electricity delivery. With increasing urbanization, electrification, and government-backed infrastructure initiatives, EPC contractors are becoming strategic partners…
Forensic Genomics Market Outlook 2035: Industry to Reach US$ 2.4 Billion, Driven …
The global forensic genomics market is witnessing rapid growth due to increasing demand for advanced DNA analysis in criminal investigations, disaster victim identification, paternity testing, and human identification. The market was valued at US$ 0.5 Bn in 2024 and is projected to reach US$ 2.4 Bn by 2035, expanding at a CAGR of 14.5% during the forecast period from 2025 to 2035. Technological innovations such as next-generation sequencing (NGS), artificial…
Carbon Capture Sorbent Market to Reach USD 7.3 Billion by 2035 Amid Rising Deman …
The global carbon capture sorbent market was valued at USD 1.8 billion in 2024 and is projected to reach USD 7.3 billion by 2035, expanding at a CAGR of 13.5% from 2025 to 2035. The market growth is driven by increasing investments in carbon capture, utilization, and storage (CCUS) technologies, stringent carbon emission regulations, rising industrial decarbonization initiatives, and growing adoption of advanced sorbent materials across power generation, cement, steel,…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
